faa semaglutide AME Minute: Why did establish rules for some diabetic medications for weight loss? Demand Rising for 'Bootlegged' Weight-Loss

Semaglutide, a GLP-1 receptor agonist used for type 2 diabetes and weight management, fundamentally changes how your body processes food and beverages through delayed gastric emptying and appetite suppression

Jayne Morgan, a cardiologist and clinical director of the Covid Task Force at the Piedmont Healthcare Corporation in Atlanta, GA, who was not involved in the study

The FLOW trial also indicated the positive effect of semaglutide in reducing the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with T2D and chronic kidney disease (CKD)

Similarly, a recent systematic review and meta-analysis reported that GLP-1 RAs and glitazones most consistently reduced dementia risk among antidiabetic medications, while metformins effects were mixed and inconsistent, likely reflecting variability in study design, treatment duration, and confounding by indication 88